Literature DB >> 26914519

Expression of epidermal stem cell markers in skin and adnexal malignancies.

S R Quist1, M Eckardt2, A Kriesche2, H P Gollnick2.   

Abstract

BACKGROUND: Epidermal stem cells are multipotent cells that maintain the skin epidermis. Potential markers for stem cells have been identified in mammalian skin from mouse experiments; however, it is unclear if stem cells also contribute to tumour formation in human skin.
OBJECTIVES: To investigate the expression of potential stem cell markers, such as leucine-rich repeat-containing G protein-coupled receptor (Lgr) 5, Lgr6, leucine-rich repeats and immunoglobulin-like domain protein 1 (Lrig1) and cytokeratin 15 (CK15) in basal cell carcinomas and tumours of the skin appendages.
METHODS: We tested 45 human basal cell carcinomas (BCCs), including superficial, nodular, adenoid, infiltrating and sclerosing types, and 38 human tumours of skin appendages, including 13 sebaceous adenomas and carcinomas, 20 eccrine sweat gland tumours and five pilomatricomas, for the expression of hair follicle stem cell markers such as Lgr5, Lrig1, CK15, β-catenin and SRY (sex determining region Y)-box 9 (SOX9), and compared these findings with those of healthy age-matched human epidermis.
RESULTS: We detected the expression of stem cell markers in all tumours tested. Regarding Lgr5, Lrig1, CK15 and SOX9, expression seemed to be lower in more aggressive tumour types, such as in the most advanced parts of infiltrating BCC, in sebaceous carcinoma and late-stage porocarcinoma, compared with less aggressive superficial or nodular BCC or early-stage porocarcinoma and sebaceous gland tumours. In aggressive, sclerosing BCC, Lrig1 and Lgr5 were downregulated but CK15, SOX9 and nuclear β-catenin were upregulated.
CONCLUSIONS: Expression of potential stem cell markers of the epidermis and hair follicles was observed in skin tumours of appendages and BCCs. However, during tumour progression, many of these markers seemed to be downregulated.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26914519     DOI: 10.1111/bjd.14494

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Distinct expression profile of stem cell markers, LGR5 and LGR6, in basaloid skin tumors.

Authors:  Bo Gun Jang; Cheol Lee; Hye Sung Kim; Myung Soo Shin; Min Seok Cheon; Jae Wang Kim; Woo Ho Kim
Journal:  Virchows Arch       Date:  2017-01-09       Impact factor: 4.064

2.  Expression of keratin 15 in dentigerous cyst, odontogenic keratocyst and ameloblastoma.

Authors:  Mohammed Amjed Alsaegh; Alaa Muayad Altaie; Shengrong Zhu
Journal:  Mol Clin Oncol       Date:  2019-01-17

3.  Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma.

Authors:  Markus Eberl; Doris Mangelberger; Jacob B Swanson; Monique E Verhaegen; Paul W Harms; Marcus L Frohm; Andrzej A Dlugosz; Sunny Y Wong
Journal:  Cancer Cell       Date:  2018-01-27       Impact factor: 31.743

Review 4.  LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor.

Authors:  Yibing Ji; Rahul Kumar; Abhiram Gokhale; Hseu-Ping Chao; Kiera Rycaj; Xin Chen; Qiuhui Li; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2021-01-18       Impact factor: 17.012

5.  Expression of Potential Dermal Progenitor Cell Markers in the Tumour and Stroma of Skin Adnexal Malignant and Benign Tumours.

Authors:  Sven R Quist; Maximilian Eckardt; André Kriesche; Harald P Gollnick
Journal:  Stem Cells Int       Date:  2019-04-01       Impact factor: 5.443

Review 6.  Epidermal stem cells in wound healing and their clinical applications.

Authors:  Ronghua Yang; Fengxia Liu; Jingru Wang; Xiaodong Chen; Julin Xie; Kun Xiong
Journal:  Stem Cell Res Ther       Date:  2019-07-29       Impact factor: 6.832

7.  LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers.

Authors:  Benjamin Sundqvist; Harri Sihto; Maria von Willebrand; Tom Böhling; Virve Koljonen
Journal:  Virchows Arch       Date:  2021-07-31       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.